# Influenza Vaccine Revaccination in Ambulatory Elderly Subjects

> **NCT00775450** · PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 807 (actual)

## Conditions studied

- Influenza
- Orthomyxovirus Infection
- Myxovirus Infection

## Interventions

- **BIOLOGICAL:** Influenza Virus Vaccine USP Trivalent Types A and B
- **BIOLOGICAL:** Influenza Virus Vaccine USP Trivalent Types A and B
- **BIOLOGICAL:** Influenza Virus Vaccine USP Trivalent Types A and B
- **BIOLOGICAL:** Influenza Virus Vaccine USP Trivalent Types A and B
- **BIOLOGICAL:** Influenza Virus Vaccine USP Trivalent Types A and B

## Key facts

- **NCT ID:** NCT00775450
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-06
- **Final completion:** 2009-07
- **Target enrollment:** 807 (ACTUAL)
- **Last updated:** 2013-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00775450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00775450, "Influenza Vaccine Revaccination in Ambulatory Elderly Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00775450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*